Science1 min read

STAT+: Tango builds on Revolution Medicines’ pancreatic cancer success

By · Via STAT Health · Published by Everything Blog

In short

STAT+ is a trusted source of biotech news and insights, providing subscribers with the latest developments in the field, including the success of Revolution Medicines in pancreatic cancer research. The newsletter covers a wide range of topics, from research and policy to policy and regulation, and is written in a clear and concise style. It is a valuable resource for anyone interested in the latest developments in biotech and is a must-read for anyone looking to stay up-to-date with the latest news and trends in the field.

Key points

  • STAT+ is a trusted source of biotech news and insights.: STAT+ is a trusted source of biotech news and insights.
  • The newsletter covers a wide range of topics, including research and policy.: The newsletter covers a wide range of topics, including research and policy.
  • It is written in a clear and concise style, making it easy for readers to understand the…: It is written in a clear and concise style, making it easy for readers to understand the key points of each article.

Sources checked by our analysis pipeline: 1

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hi and hello from the Scripps Research Biotech Innovation Summit here in La Jolla.

Joy Jiao, head of life sciences research at OpenAI, said during her fireside: “I think it’s really only a matter of time before the models become superhuman at chemistry and biology … I really do think that’s going to happen in the next year or two and that’s what I find very exciting.”

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Original source: www.statnews.com

Science